Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease
White, M.D.; Farmer, M.; Mirabile, I.; Brandner, S.; Collinge, J.; Mallucci, G.R.
Proceedings of the National Academy of Sciences of the United States of America 105(29): 10238-10243
2008
ISSN/ISBN: 0027-8424
PMID: 18632556
DOI: 10.1073/pnas.0802759105
Accession: 023600443
Prion diseases are fatal neurodegenerative conditions for which there is no effective treatment. Prion propagation involves the conversion of cellular prion protein, PrP(C), to its conformational isomer, PrP(Sc), which accumulates in disease. Here, we show effective therapeutic knockdown of PrP(C) expression using RNAi in mice with established prion disease.
PDF emailed within 0-6 h: $19.90
Related References
Pfeifer, A.; Eigenbrod, S.; Al-Khadra, S.; Hofmann, A.; Mitteregger, G.; Moser, M.; Bertsch, U.; Kretzschmar, H. 2006: Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice Journal of Clinical Investigation 116(12): 3204-3210Nakagaki, T.; Satoh, K.; Ishibashi, D.; Fuse, T.; Sano, K.; Kamatari, Y.O.; Kuwata, K.; Shigematsu, K.; Iwamaru, Y.; Takenouchi, T.; Kitani, H.; Nishida, N.; Atarashi, R. 2013: FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice Autophagy 9(9): 1386-1394
Mallucci, G.R.; White, M.D.; Farmer, M.; Dickinson, A.; Khatun, H.; Powell, A.D.; Brandner, S.; Jefferys, J.G.R.; Collinge, J. 2007: Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice Neuron 53(3): 325-335
Nishida, N.; Tremblay, P.; Sugimoto, T.; Shigematsu, K.; Shirabe, S.; Petromilli, C.; Erpel, S.P.; Nakaoke, R.; Atarashi, R.; Houtani, T.; Torchia, M.; Sakaguchi, S.; DeArmond, S.J.; Prusiner, S.B.; Katamine, S. 1999: A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination Laboratory Investigation; a Journal of Technical Methods and Pathology 79(6): 689-697
Hyeon, J.W.; Noh, R.; Choi, J.; Lee, S.M.; Lee, Y.S.; An, S.S.A.; No, K.T.; Lee, J. 2020: BMD42-2910, a Novel Benzoxazole Derivative, Shows a Potent Anti-prion Activity and Prolongs the Mean Survival in an Animal Model of Prion Disease Experimental Neurobiology 29(1): 93-105
Serra, F.; Dudas, S.; Torres, J.M.; Anderson, R.; Oevermann, A.; Espinosa, J.C.; Czub, S.; Seuberlich, T. 2018: Presumptive BSE cases with an aberrant prion protein phenotype in Switzerland, 2011: Lack of prion disease in experimentally inoculated cattle and bovine prion protein transgenic mice Transboundary and Emerging Diseases 65(5): 1348-1356
Wagner, W.; Reuter, A.; Hüller, P.; Löwer, J.; Wessler, S. 2012: Peroxiredoxin 6 promotes upregulation of the prion protein (PrP) in neuronal cells of prion-infected mice Cell Communication and Signaling: Ccs 10(1): 38
Sakudo, A.; Wu, G.; Onodera, T.; Ikuta, K. 2008: Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line Biochemical and Biophysical Research Communications 365(1): 164-169
Tal, Y.; Souan, L.; Cohen, I.R.; Meiner, Z.; Taraboulos, A.; Mor, F. 2002: Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice Journal of Neuroscience Research 71(2): 286-290
Morris, R.J.; Parkyn, C.J.; Jen, A. 2006: Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease Febs Letters 580(23): 5565-5571
Voigtländer, T.; Klöppel, S.; Birner, P.; Jarius, C.; Flicker, H.; Verghese-Nikolakaki, S.; Sklaviadis, T.; Guentchev, M.; Budka, H. 2001: Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases Acta Neuropathologica 101(5): 417-423
Nakagaki, T.; Ishibashi, D.; Mori, T.; Miyazaki, Y.; Takatsuki, H.; Tange, H.; Taguchi, Y.; Satoh, K.; Atarashi, R.; Nishida, N. 2020: Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 17(4): 1850-1860
Schmitz, M.; Lüllmann, K.; Zafar, S.; Ebert, E.; Wohlhage, M.; Oikonomou, P.; Schlomm, M.; Mitrova, E.; Beekes, M.; Zerr, I. 2014: Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases Neurobiology of Aging 35(5): 1177-1188
Montrasio, F.; Cozzio, A.; Flechsig, E.; Rossi, D.; Klein, M.A.; Rülicke, T.; Raeber, A.J.; Vosshenrich, C.A.; Proft, J.; Aguzzi, A.; Weissmann, C. 2001: B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice Proceedings of the National Academy of Sciences of the United States of America 98(7): 4034-4037
Jeong, J.-K.; Moon, M.-H.; Seol, J.-W.; Seo, J.-S.; Lee, Y.-J.; Park, S.-Y. 2011: Prion peptide-mediated cellular prion protein overexpression and neuronal cell death can be blocked by aspirin treatment International Journal of Molecular Medicine 27(5): 689-693
Telling, G.C.; Scott, M.; Schatzl, H.; Foster, D.; Yang, S.L.; Torchia, M.; Cohen, F.E.; Dearmond, S.J.; Prusiner, S.B. 1994: Prion transmission from humans to transgenic mice expression chimeric human mouse prion protein provides evidence for a species-specific factor in prion propagation Molecular Biology of the Cell 5(Suppl ): 473A
Schwarz, A.; Krätke, O.; Burwinkel, M.; Riemer, C.; Schultz, J.; Henklein, P.; Bamme, T.; Baier, M. 2003: Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent Neuroscience Letters 350(3): 187-189
Nicolas, O.; Gavín, R.; Braun, N.; Ureña, Jús.Mariano.; Fontana, X.; Soriano, E.; Aguzzi, A.; del Río, Jé.Antonio. 2007: Bcl-2 overexpression delays caspase-3 activation and rescues cerebellar degeneration in prion-deficient mice that overexpress amino-terminally truncated prion Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 21(12): 3107-3117
Cortez, L.M.; Campeau, J.; Norman, G.; Kalayil, M.; Van der Merwe, J.; McKenzie, D.; Sim, V.L. 2015: Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease Journal of Virology 89(15): 7660-7672
Grossman, A.; Zeiler, B.; Sapirstein, V. 2003: Prion protein interactions with nucleic acid: Possible models for prion disease and prion function Neurochemical Research 28(6): 955-963